Edition:
United States

PLx Pharma Inc (PLXP.OQ)

PLXP.OQ on NASDAQ Stock Exchange Capital Market

6.65USD
15 Dec 2017
Change (% chg)

$-0.25 (-3.62%)
Prev Close
$6.90
Open
$6.90
Day's High
$6.90
Day's Low
$6.60
Volume
1,548
Avg. Vol
4,448
52-wk High
$21.60
52-wk Low
$5.60

Chart for

About

PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325... (more)

Overall

Beta: 1.82
Market Cap(Mil.): $58.00
Shares Outstanding(Mil.): 8.72
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-Park West Asset Management reports 12.3 pct stake in PLx Pharma

* Park West Asset Management Llc reports 12.3 percent stake in PLx Pharma Inc ‍​as of November 20 - SEC filing

Nov 20 2017

BRIEF-PLx Pharma Inc. Reports third quarter 2017 results

* Q3 loss per share $0.44 Source text for Eikon: Further company coverage:

Nov 09 2017

BRIEF-PLx Pharma reports Q2 loss per share $0.36

* Q2 loss per share $0.36 Source text for Eikon: Further company coverage:

Aug 10 2017

BRIEF-Plx Pharma, unit entered a loan and security agreement

* Plx Pharma - ‍on Aug 9, co and its unit entered a loan and security agreement with Silicon Valley Bank​

Aug 10 2017

Earnings vs. Estimates